peptide mapping raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-06. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Nuclear batteries use small amounts (milligrams and microcuries) of radioisotopes with high energy densities. In one betavoltaic device design, radioactive material sits atop a device with adjacent layers of P-type and N-type silicon. Ionizing radiation directly penetrates the junction and creates electron–hole pairs. Nuclear isomers could replace other isotopes, and with further development, it may be possible to turn them on and off by triggering decay as needed. Current candidates for such use include 108Ag, 166Ho, 177Lu, and 242Am. As of 2004, the only successfully triggered isomer was 180mTa, which required more photon energy to trigger than was released. An isotope such as 177Lu releases gamma rays by decay through a series of internal energy levels within the nucleus, and it is thought that by learning the triggering cross sections with sufficient accuracy, it may be possible to create energy stores that are 106 times more concentrated than high explosive or other traditional chemical energy storage.
=== In diagnosis === Lactoferrin levels in tear fluid have been shown to decrease in dry eye diseases such as Sjögren's syndrome. A rapid, portable test utilizing microfluidic technology has been developed to enable measurement of lactoferrin levels in human tear fluid at the point-of-care with the aim of improving diagnosis of Sjögren's syndrome and other forms of dry eye disease.
He previously worked as an analyst with the International Crisis Group.; co-founder of J Street and has served on the organization's advisory council; also a founding board member of Molad: The Center for the Renewal of Israeli Democracy as well as the Diaspora Alliance; serves on board of New Israel Fund and as trustee of Rockefeller Brothers Fund; editor with Foreign Policy magazine as editor of their Middle East Channel He publishes and speaks widely on matters related to Israel and Palestine.; has appeared on and written for The Nation, The New York Times, Ha'aretz, the BBC, Al Jazeera, and CNN. Eylon Levy (born London, 1991) is an official Israeli government spokesman, serving since the start of Gaza war. He served previously as international media advisor to President Isaac Herzog, after a career as a television news anchor at i24News and IBA News. Levy's work has appeared in Newsweek, Jerusalem Post, Times of Israel, The Daily Caller, Arutz Sheva/Israel National News, Tablet Magazine, The Washington Post, The Guardian, and The Daily Telegraph. Martin Lewis (financial journalist) (born 9 May 1972) financial journalist and broadcaster, has worked for BBC, Channel 5 (British TV channel), ITV's This Morning (TV programme) and written for The Sunday Post, The Yorkshire Post, the Manchester Evening News, Express & Star, has been a columnist for The Sunday Times, News of the World, The Guardian and the Sunday Express. Tim Lott(born 23 January 1956); author and journalist for The Guardian.
== Further reading == Laurence, J (2015). "Centennial celebration of Translational Research: The Journal of Laboratory and Clinical Medicine". Translational Research. 165 (1): 1–6. doi:10.1016/j.trsl.2014.08.004. PMID 25301250. Hammerschmidt, DE (2004). "A new look and a heightened focus: Translational medicine and the Journal of Laboratory and Clinical Medicine". Journal of Laboratory and Clinical Medicine. 144 (1): 5–6. doi:10.1016/j.lab.2004.05.006. Vaughan, WT (1940). "We celebrate our silver anniversary". Journal of Laboratory and Clinical Medicine. 26 (1): 1–3.
== Side effects == The side effects of trimipramine have been said to be similar to those of other tertiary amine TCAs, with a preponderance of anticholinergic and sedative effects. However, trimipramine has also been said to be associated with a different side effect profile compared to other TCAs and in general with fewer side effects, chiefly due to its lack of norepinephrine reuptake inhibition and relatively lower anticholinergic effects (although it is still a potent anticholinergic). Somnolence is the most common side effect of the drug. Dry mouth is the most common anticholinergic side effect, but others like constipation, urinary retention, and blurred vision are also present. Such effects, in any case, may be treated with bethanechol. It is described as being associated with minimal or no orthostatic hypotension, at least in comparison to clomipramine, in spite of its potent and comparable activity as an alpha-1 blocker. However, it has also been said to have a rate of orthostatic hypotension similar to that of other TCAs. Trimipramine is said to be less epileptogenic than other TCAs, although seizures have still been reported in association with it. It is also less cardiotoxic than other TCAs and cardiotoxicity is said to be minimal, with a "very favorable profile". Heavy exposure to any tricyclic antidepressants was associated with an elevated rate ratio for breast cancer 11–15 years later.
Sources: en.wikipedia.org
Deupsilocin (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; former developmental code names HLP003 and CYB0003), also known as deuterated psilocin or as psilocin-d10, is a psychedelic drug of the tryptamine family related to psilocin which is under development for the treatment of major depressive disorder, alcoholism, and other psychiatric disorders. It is taken orally. The drug is a deuterated isotopologue of psilocin with altered pharmacokinetics.
==== Lower side effects ==== Both photosensitizers and photothermal agents have some degree of selectivity for target cells over healthy human cells, but in utilizing both of these mechanisms this selectivity is bolstered. Increased antibiotic efficacy indicates a lower likelihood of requiring follow-up treatments, so the damage is minimal. In addition, some of these combination phototherapeutic agents have antioxidant/reactive oxygen scavenging properties, reducing the amount of collateral damage sustained by the surrounding human cells.
=== Chronic === Proprioception, a sense vital for rapid and proper body coordination, can be permanently lost or impaired as a result of genetic conditions, disease, viral infections, and injuries. For instance, patients with joint hypermobility or Ehlers–Danlos syndromes, genetic conditions that result in weak connective tissue throughout the body, have chronic impairments to proprioception. Autism spectrum disorder and Parkinson's disease can also cause chronic disorder of proprioception. In regards to Parkinson's disease, it remains unclear whether the proprioceptive-related decline in motor function occurs due to disrupted proprioceptors in the periphery or signaling in the spinal cord or brain. In rare cases, viral infections result in a loss of proprioception. Ian Waterman and Charles Freed are two such people that lost their sense of proprioception from the neck down from supposed viral infections (i.e. gastric flu and a rare viral infection). After losing their sense of proprioception, Ian and Charles could move their lower body, but could not coordinate their movements. However, both individuals regained some control of their limbs and body by consciously planning their movements and relying solely on visual feedback. Interestingly, both individuals can still sense pain and temperature, indicating that they specifically lost proprioceptive feedback, but not tactile and nociceptive feedback. The impact of losing the sense of proprioception on daily life is perfectly illustrated when Ian Waterman stated, "What is an active brain without mobility".
== Design == The bag is typically partially folded when it is placed in a microwave, and inflates as a result of steam pressure from the heated kernels. Microwave popcorn bags are designed to avoid popped-kernel scorching, an undesirable effect that takes place when popped kernels are heated above 300 °F (150 °C). A susceptor—usually a metalized film laminated onto the paper of the bag—absorbs microwaves and concentrates heat at the film interface, thus ensuring a heat distribution focused on the hard-to-heat flavor coating so that the unpopped kernels are evenly coated prior to popping, thereby ensuring even flavor throughout the product. Some popcorn is flawed and will not pop because of possible damage to the shell, which allows the steam to escape. These unpopped kernels are known as "old men" or "grandpas". An early susceptor popcorn bag design was patented by The American Company General Mills in 1981 (US Patent #4,267,420).
After the Dissolution of the Soviet Union in 1990, Cuba lost access to its primary financial partners, and was facing a massive economic collapse. In order to stave off the effects of economic isolation, they authorized the transformation of formerly state-owned enterprise into a new kind of joint private-public company to develop hotels and rejuvenate Cuba's tourism sector. The Communist Party of Cuba allowed Cuban civil society organizations to reform, allowing hundreds of non-governmental organizations to form in Havana, and especially relaxed its regulations on membership in Catholic Church. They relaxed regulations on international charities, including Caritas Internationalis. When the World Wide Web was created in 1991, Cuba authorized its citizens access to the internet. In 1991, the Congress of the Communist Party of Cuba officially authorized registered Communists to join the Freemasons (and churches). Membership in the Grand Lodge of Cuba rose sharply, and Cuba fully opened the country to Freemasonry. Masons were allowed to attend public events adorned in Masonic regalia. New lodges were opened across the country. Freemasons were also allowed to lay wreaths at the graves of deceased Brothers. After 1991, newly initiated Freemasons included high-ranking leaders of the Communist Party, government officials, members of Cuban dissident movements, antigovernment activists, and others. In 1993, Caridad del Rosario Diego Bello was appointed head of OAR.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.